Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 756 clinical trials
Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

Patients suffering from uveal melanoma (typed positive for monosomy 3 and without evidence for metastases) will be vaccinated over a period of 2 years with Dendritic Cell loaded with autologous

metastasis
therapeutic autologous dendritic cells
  • 28 views
  • 09 May, 2021
  • 12 locations
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma

The researchers are doing this study to find out whether the combination of axitinib and nivolumab is an effective and safe treatment for people with advanced or metastatic mucosal melanoma that

  • 0 views
  • 25 Jul, 2022
  • 1 location
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

This research study is investigating Binimetinib and Belinostat in participants with metastatic uveal melanoma. The research study will test the study drugs to see if the combination of

  • 0 views
  • 10 Jul, 2022
  • 1 location
ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases

This is a Phase 2 multicenter, open label, non-randomized, interventional study enrolling 53 patients.The objectives and purposes of the clinical study described herein are to determine if concomitant Pembrolizumab (Keytruda) and ECT treatments are safe and able to improve local and systemic response rates.ECT will be performed with the CLINIPORATOR …

unresectable melanoma
metastasis
melanoma stage
advanced melanoma
brain metastases
  • 7 views
  • 25 May, 2022
  • 1 location
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma

microenvironment and benefit patients with mucosal melanoma.

immunologic adjuvant
gilbert's syndrome
mucosal melanoma
measurable disease
nivolumab
  • 0 views
  • 16 Jun, 2022
  • 1 location
A Phase I/II, Multi-center, Open Label Study of DYP688 in Patients With Metastatic Uveal Melanoma (MUM) and Other GNAQ/11 Mutant Melanomas

a single agent in patients with metastatic uveal melanoma (MUM) and other melanomas harboring GNAQ/11 mutations.

  • 0 views
  • 14 Sep, 2022
  • 2 locations
ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma

With the introduction of checkpoint inhibitors substantial improvements have been made in the treatment of malignant melanoma (MM). Despite this still a a subset of patients, approximately 50

cancer
direct bilirubin
pembrolizumab
cyclophosphamide
metastatic melanoma
  • 0 views
  • 25 Sep, 2021
  • 1 location
Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma

This research study is designed to better understand the role of genetics, sun-exposure and phenotypic factors in melanoma.

Accepts healthy volunteers
  • 0 views
  • 24 Apr, 2022
  • 1 location
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

pembrolizumab on local tumor control in mucosal melanoma patients. Treatment effect will be compared with historical radiation therapy-alone control data.

  • 0 views
  • 14 Mar, 2022
  • 1 location
Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study

A mucosal melanoma postoperative adjuvant treatment of multicenter, randomized, double-blind, placebo-controlled phase II study, evaluation of mucosal melanoma patients accept completely

  • 0 views
  • 24 Mar, 2022
  • 1 location